Tobacco/Warning Letter·FDA Warning Letters

Warning Letter — mikuvape.com

MediumPublished Aug 18, 2026· AI-analyzed Aug 18, 2026View original FDA source

AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.

What happened

The FDA issued a Warning Letter to mikuvape.com on August 7, 2026, following an evaluation by the Center for Tobacco Products regarding the sale and distribution of unauthorized tobacco products.

Who it affects

This notice affects mikuvape.com and potentially other online retailers and manufacturers of electronic nicotine delivery systems (ENDS) operating without appropriate marketing authorizations.

Why it matters

The issuance of this letter indicates continued FDA enforcement pressure on the e-commerce sector of the tobacco industry. It suggests that the CTP is actively monitoring online platforms for the sale of products that have not completed the required premarket review process, posing significant enforcement risks for unauthorized digital distributors.

Practical takeaway

Regulatory teams should ensure all ENDS products offered for sale have the requisite premarket authorization. Compliance departments should audit online storefronts to confirm that product listings do not circumvent Center for Tobacco Products (CTP) regulations.

FDA source material

FDA Warning Letter issued to: mikuvape.com. 08/07/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mikuvapecom-735084-08072026

Open in openFDA / FDA.gov

AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.

Warning Letter — mikuvape.com

More from Tobacco